ORGN Earnings

ORGN reported its earnings on 2026-03-12, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following ORGN's earnings announcement on 2026-03-12, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, ORGN's stock price tends to shift by an average of -3.52% in the 10 days leading up to earnings and -12.24% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate ORGN's annual revenue to reach 29.10M, while the EPS is projected at -0.07. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates revised downward by -68.63% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ORGN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved revised downward by -68.63%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ORGN's stock price typically moves by -3.52% in the 10 days before its earnings and -12.24% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.07 and revenue of 29.10M.

The earnings call reveals significant challenges: delays in manufacturing output, reduced revenue guidance, and strategic uncertainties. The Q&A highlights management's evasive responses and lack of clear timelines, further eroding confidence. Despite some positive notes on financing and partnerships, the overall sentiment is negative due to the downward revision of guidance and operational delays, which are likely to weigh heavily on the stock price in the near term.